Sharifa M Alasiry

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Blood Brain Barrier

Cognitive Decline

Molecular Docking

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Danish Iqbal, Md Tabish Rehman, Mohamed F Alajmi, Mohammed Alsaweed, Qazi Mohammad Sajid Jamal, Sharifa M Alasiry, Awatif B Albaker, Munerah Hamed, Mehnaz Kamal, Hind Muteb Albadrani
Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Danish Iqbal, Md Tabish Rehman, Mohamed F Alajmi, Mohammed Alsaweed, Qazi Mohammad Sajid Jamal, Sharifa M Alasiry, Awatif B Albaker, Munerah Hamed, Mehnaz Kamal, Hind Muteb Albadrani
Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Danish Iqbal, Md Tabish Rehman, Mohamed F Alajmi, Mohammed Alsaweed, Qazi Mohammad Sajid Jamal, Sharifa M Alasiry, Awatif B Albaker, Munerah Hamed, Mehnaz Kamal, Hind Muteb Albadrani
Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Danish Iqbal, Md Tabish Rehman, Mohamed F Alajmi, Mohammed Alsaweed, Qazi Mohammad Sajid Jamal, Sharifa M Alasiry, Awatif B Albaker, Munerah Hamed, Mehnaz Kamal, Hind Muteb Albadrani
Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)